Saraswati, Sarita <br/><br/>
α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway.  [electronic resource] 

 -  Molecular cancer  Nov 2013 
 - 147 p.  digital 
<br/><br/> Publication Type: Journal Article; Retracted Publication 
<br/><br/><label>ISSN: </label>1476-4598 
<br/><br/><label>Standard No.: </label>10.1186/1476-4598-12-147  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Gene Expression Regulation, Neoplastic<br/>Human Umbilical Vein Endothelial Cells<br/>Humans<br/>Male<br/>Mice<br/>Mice, Nude<br/>Models, Molecular<br/>Molecular Docking Simulation<br/>Molecular Targeted Therapy<br/>Neovascularization, Pathologic--drug therapy<br/>Polycyclic Sesquiterpenes<br/>Prostate--metabolism<br/>Prostatic Neoplasms--drug therapy<br/>Proto-Oncogene Proteins c-akt--genetics<br/>Rats<br/>Sesquiterpenes--pharmacology<br/>Signal Transduction--drug effects<br/>Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays